One-year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations

Transfusion

Volumn 49, Issue 6, 2009, Pages 1126-1135

  Phikulsod, Soisaang ^a   Oota, Sineenart ^b   Tirawatnapong, Thaweesak ^b   Sakuldamrongpanich, Tasanee ^b   Chalermchan, Wilai ^b   Louisirirotchanakul, Suda ^b   Tanprasert, Srivilai ^b   Chongkolwatana, Viroje ^b   Kitpoka, Pimpun ^b   Phanuphak, Praphan ^b   Wasi, Chantapong ^b   Nuchprayoon, Chaivej ^b  

^a THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEPATITIS; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; CONTROLLED STUDY; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MAJOR CLINICAL STUDY; NUCLEIC ACID AMPLIFICATION; SENSITIVITY AND SPECIFICITY; THAILAND; VIRUS LOAD;

BLOOD DONORS; DNA, VIRAL; FOLLOW-UP STUDIES; GENOTYPE; HEPACIVIRUS; HEPATITIS B VIRUS; HIV-1; HUMANS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; THAILAND;

EID: 66549108732     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02176.x     Document Type: Article

References (24)

1. Stramer SL, Glynn SA, Kleinman SH, Strong DM, Caglioti S, Wright DJ, Dodd RY, Busch MP. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med 2004 351 : 760 8.
2. Coste J, Reesink HW, Engelfriet CP, Laperche S, Brown S, Busch MP, Cuijpers HT, Elgin R, Ekermo B, Epstein JS, Flesland O, Heier HE, Henn G, Hernandez JM, Hewlett IK, Hyland C, Keller AJ, Krusius T, Levicnik-Stezina S, Levy G, Lin CK, Margaritis AR, Muylle L, Niederhauser C, Pastila S, Pillonel J, Pineau J, van der Poel CL, Politis C, Roth WK, Sauleda S, Seed CR, Sondag-Thull D, Stramer SL, Strong M, Vamvakas EC, Velati C, Vesga MA, Zanetti A. Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003. Vox Sang 2005 88 : 289 303. (Pubitemid 40704905)
3. Roth WK, Weber M, Buhr S, Drosten C, Weichert W, Sireis W, Hedges D, Seifried E. Yield of HCV and HIV-1 NAT after screening of 3.6 million blood donations in central Europe. Transfusion 2002 42 : 862 8.
4. CDC. West Nile virus activity - United States, October 10-16, 2002, and update on West Nile virus infections in recipients of blood transfusion. Morb Mortal Wkly Rep 2002 51 : 929 31.
5. Kleinman S, Glynn SA, Busch M, Todd D, Powell L, Pietrelli L, Nemo G, Schreiber G, Bianco C, Katz L. The 2003 West Nile virus United States epidemic: the America's Blood Centers experience. Transfusion 2005 45 : 469 79.
6. Stramer AL, Fang CT, Foster GA, Brodsky J, Dodd RY. West Nile virus among blood donors in the United States, 2003 and 2004. N Engl J Med 2005 353 : 451 9.
7. Ishida T, Takao S, Settheetham-Ishida W, Tiwawech D. Prevalence of hepatitis B and C virus infection in rural ethnic populations of Northern Thailand. J Clin Virol 2002 24 : 31 5.
8. Luksamijarulkul P, Thammata N, Tiloklurs M. Seroprevalence of hepatitis B, hepatitis C and human immunodeficiency virus among blood donors, Phitsanulok Regional Blood Center, Thailand. Southeast Asian J Trop Med Public Health 2002 33 : 272 9.
9. Wiwanitkit V. Anti HCV seroprevalence among the voluntary blood donors in Thailand. Hematology 2005 10 : 431 3.
10. Liu CJ, Chen DS, Chen PJ. Epidemiology of HBV infection in Asian blood donors: emphasis on occult HBV infection and the role of NAT. J Clin Virol 2006 36 : S33 44.
11. Commanor L, Holland P. Hepatitis B virus blood screening; unfinished agendas. Vox Sang 2006 91 : 1 12. (Pubitemid 43822298)
12. Margaritis AR, Brown SM, Seed CR, Kiely P, D'Agostino B, Keller AJ. Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA. Transfusion 2007 47 : 1783 93.
13. Wong I, Lam S, Teo D. Overview of nucleic acid testing (NAT) on blood donations in Singapore. Vox Sang 2005 89 : 19.
14. Yugi HS, Satake M, Tadodoro K. Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology in Japan. Vox Sang 2005 89 : 265. (Pubitemid 41641108)
15. Yoshikawa A, Gotanda Y, Itabashi M, Minegishi K, Nishioka K. The Japanese Red Cross NAT Screening Research Group. Hepatitis B NAT virus-positive donors in the early and late stages of HBV infection: analyses of the WP and kinetics of HBV DNA. Vox Sang 2005 88 : 77 86. (Pubitemid 40362922)
16. External review of the health sector response to HIV/AIDS in Thailand. A Joint Publication of the Ministry of Health, Thailand, and the World Health Organisation, Regional Office for South-East Asia, 2005:1-68.
17. Assal A, Barlet V, Deschaseaux M, Dupont I, Gallian P, Guitton C, Morel P, David B, De Micco P. Comparison of the analytical and operational performance of two automated NAT blood screening systems: procleix TIGRIS and cobas s 201. Transfusion 2009 49 : 289 300.
18. Linauts S, Saldanha J, Strong DM. PRISM hepatitis B surface antigen detection of hepatitis B virus minipool nucleic acid yield samples. Transfusion 2008 48 : 1376 82.
19. Roth KW, Weber M, Petersen D, Drosten C, Buhr S, Sireis W, Weichert W, Hedges D, Seifried E. NAT for HBV and anti-HBc testing increase blood safety. Transfusion 2002 42 : 869 75.
20. Allain JP. Occult hepatitis B infection: implications in transfusion. Vox Sang 2004 86 : 83 91.
21. Li L, Chen PJ, Chen MH, Chak KF, Lin KS, Lin Tsai SJ. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infection and closing the serologic window for hepatitis C virus. Transfusion 2008 48 : 1198 206.
22. Jarvis L, Becker J, Tender A, Cleland A, Queiros L, Aquiar A, Azevedo J, Aprili G, Bressan F, Torres P, Nieto S, Ursitti A, Montoro J, Vila E, Ramada C, Saldanha J. Evaluation of the Roche cobas s 201 system and cobas TaqScreen multiplex test for blood screening: a European multicenter study. Transfusion 2008 48 : 1853 61.
23. Yoshikawa A, Gotanda Y, Itabashi M, Minegishi K, Kanenitsu K, Nishioka K, the Japanese Red Cross Blood Screening Group. Hepatitis NAT virus-positive blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA. Vox Sang 2005 88 : 77 86. (Pubitemid 40362922)
24. Matsumoto C, Tadokoro K, Fujimura K, Hirakawa S, Mitsunaga S, Juji T. Analysis of HBV infection after blood transfusion in Japan through investigation of a comprehensive donor specimen repository. Transfusion 2001 41 : 874 84.